跳至主要内容
临床试验/NCT01238510
NCT01238510已完成4 期

Comparison Between Provisional Versus Routine Kissing Balloon Technique After Main Vessel Crossover Stenting for Bifurcated Lesions.

Saiseikai Yokohama City Eastern Hospital3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2010年3月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120
试验地点
3
主要终点
Rate of positive dipyridamole stress technetium scintigraphy

研究概览

简要总结

In the setting of single stent strategy for treatment of bifurcation, we investigate to compare simple strategy as "provisional final kissing balloon technique(fKBT)" to complex one as "routine FKBT", focusing on actual myocardial ischemia assessed by scintigraphy in 7-month and to examine optimal endpoint of side branch ostium.

详细描述

Final kissing balloon technique (FKBT) is effective and accepted technique for the treatment of bifurcation. However, in complex lesion or anatomy, much procedure-time and contrast media are needed to accomplish this technique. Recent FFR study for jailed side branch (SB) demonstrated that angiographic severe stenosis at SB ostium includes "pseudo-stenosis" and stent-deployment jailing SB without FKBT has comparable impact on clinical outcome with FKBT strategy. Considering simple technique for bifurcation, we sought to investigate to compare "provisional FKBT" with "routine FKBT", focusing on actual myocardial ischemia assessed by scintigraphy in 7 month and to examine optimal endpoint of SB ostium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (Patient) Patient who has angina or documented ischemia, Patients who are eligible for drug eluting stent, Age >=18, Patient who received informed consent, Patient who can receive dipyridamole-stress-technetium scintigraphy.
  • (Lesion) Non-left main bifurcation except for Medina class (0,0,1), De-Novo lesion, Vessel diameter in visual (main vessel>2.5mm, side branch >2.0mm), SB lesion length <5mm in visual estimate, MB lesion length < 46mm in visual, TIMI 3 in main vessel as well as side branch,

排除标准

  • (Patient) Patients who is pregnant, Patient contraindicated for antiplatelet therapy, Patients whose ejection fraction is less than 30%, Patients who has renal dysfunction, creatinine >=2.3, Patients who has live dysfunction, Patients who cannot agree with informed consent, Patient whose life expectancy is less than 1 year, Patients contraindicated for dipyridamole-stress-technetium scintigraphy.
  • (Lesion) Target site of acute myocardial infarction, Left main disease, In-Stent restenosis lesion, Bypass graft, Chronic total occlusion, Main vessel reference diameter >4.5mm, Bifurcation lesion that needs intended 2 stent strategy, Highly tortus and calcified lesion,

结局指标

主要结局

Rate of positive dipyridamole stress technetium scintigraphy

时间窗: 7 month

次要结局

  • Composite of major cardiac adverse events(MACE)(8 month)
  • Angiographic restenosis rate in main vessel(8 month)
  • Fluoroscopic time(after procedure)
  • Amount of contrast media(after procedure)
  • Number of stent and wire use(after procedure)
  • Diameter stenosis and late loss in side branch(8 month)
  • Regional summed difference score(7 month)

研究者

发起方
Saiseikai Yokohama City Eastern Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Masahiro Yamawaki

Cardiology

Saiseikai Yokohama City Eastern Hospital

研究点 (3)

Loading locations...

相似试验